OR WAIT null SECS
May 02, 2014
Once an afterthought, packaging has now become an essential component of biopharmaceutical product development and marketing.
Zero-order release of a freely water-soluble active drug can be obtained using release-controlling polymers.
With the rising threat of antibiotic resistance and a diminishing R&D pipeline for novel drugs, Europe must step up its game to address this growing problem.
Common challenges and key considerations when developing a freeze-drying cycle for protein pharmaceuticals.
New formulations and expanded vaccine production are encouraged.
May 01, 2014
Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.
April 30, 2014
TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.
April 15, 2014
Experts share insights on how product appearance such as size, shape, color, and imprint can make a difference in reducing medication errors.
Lifecycle management opportunities are impacting the development of controlled-release technologies for solid-dosage drugs.
The author examines the effect of compaction force, gap width, and sieve setup on granule size.